WPI 339 (Diclofenac sodium delayed release 75 mg)
Pill imprint WPI 339 has been identified as Diclofenac sodium delayed release 75 mg.
Diclofenac is used in the treatment of back pain; pain; osteoarthritis; muscle pain; migraine (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. There is positive evidence of human fetal risk during pregnancy. Diclofenac 75 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WPI 339 (Diclofenac sodium delayed release 75 mg)
Diclofenac sodium delayed release
- Imprint:
-
WPI 339
- Strength:
- 75 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- 00591-0339
More resources
Diclofenac sodium delayed release is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
